GSK - GlaxoSmithKline PLC ADR - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

GSK is currently covered by 4 analysts

GlaxoSmithKline PLC ADR's activity chart (see below) currently has 156 price targets and 135 ratings on display. The stock rating distribution of GSK is 75% HOLD and 25% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 33.56% with an average time for these price targets to be met of 532.7 days.

Highest price target for GSK is $51, Lowest price target is $46.

Most recent stock forecast was given by GRAHAM PERRY from JPMORGAN on 24-Jul-2026. First documented stock forecast 28-Jul-2014.

Currently out of the existing stock ratings of GSK, 3 are a HOLD (75%), 1 are a SELL (25%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 09-Dec-2015

$20.57

2 months 9 days ago
(24-Jul-2026)

2/3 (66.67%)

$-11.56 (-35.98%)

4036

Hold Since 06-Jan-2026

8 months 27 days ago
(06-Jan-2026)

0/13 (0%)

$-14.35 (-43.95%)

Sell Since 03-Jan-2023

$17.1

9 months 23 days ago
(10-Dec-2025)

0/2 (0%)

$-13.25 (-43.66%)

Hold Since 06-Feb-2025

10 months 21 days ago
(12-Nov-2025)

0/11 (0%)

$-12.38 (-34.45%)

Hold Since 06-Sep-2025

$45

$-2.03 (-4.32%)

1 years 27 days ago
(06-Sep-2025)

3/3 (100%)

$5.89 (15.06%)

1661

Show more analysts

Please expand the browser size to see the chart

What is GSK (GlaxoSmithKline PLC ADR) average time for price targets to be met?

On average it took 533 days for the stock forecasts to be reached, with an average price target met ratio of 33.56%.

Which analyst most recently updated their price target on GSK (GlaxoSmithKline PLC ADR)?

Graham Perry

Which analyst has the most public recommendations on GSK (GlaxoSmithKline PLC ADR)?

Graham Perry works at BAML and has 4 price targets and 7 ratings on GSK

Which analyst is the currently most bullish on GSK (GlaxoSmithKline PLC ADR)?

Graham Perry with the highest potential upside of $0

Which analyst is the currently most reserved on GSK (GlaxoSmithKline PLC ADR)?

Andrew Jeffrey with the lowest potential downside of -$54.21
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?